KJ

AstraZeneca admits for first time its Covid vaccine CAN cause rare side effect AstraZeneca has admitted in court for the first time that its Covid jab can cause a deadly blood clotting side effect. The exceedingly rare reaction is at the heart of a multi million-pound class action by dozens of families who allege they, or their loved ones, were maimed or killed by the pharmaceutical titan's 'defective' vaccine.  Cambridge-based AstraZeneca, acknowledged in a legal document submitted to the High Court in February that its vaccine 'can, in very rare cases, cause TTS'. TTS is short for thrombosis with thrombocytopenia syndrome – a medical condition where a person suffers blood clots along with a low platelet count. Platelets typically help the blood to clot.  AstraZeneca's admission could lead to pay-outs on a case-by-case basis.   Although accepted as a potential side effect for two years, it marks the first time the company has admitted in court that its jab can